4//SEC Filing
McFarlane Neil F. 4
Accession 0001681098-25-000005
CIK 0001434647other
Filed
Oct 9, 8:00 PM ET
Accepted
Oct 10, 7:17 PM ET
Size
9.1 KB
Accession
0001681098-25-000005
Insider Transaction Report
Form 4
McFarlane Neil F.
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2025-10-10+50,000→ 241,516 total - Sale
Common Stock
2025-10-10$10.82/sh−19,500$210,908→ 222,016 total - Exercise/Conversion
Restricted Stock Unit
2025-10-10−50,000→ 100,000 totalExercise: $0.00→ Common Stock (50,000 underlying)
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
- [F2]Adoption date of referenced 10b5-1(c) plan is: 03-21-2025.
- [F3]25% of the RSUs vested and settled on each of October 10, 2024 and October 10, 2025. The remaining 50% of the shares will vest in equal annual installments thereafter, provided that at the relevant vesting dates the Reporting Person's employment relationship has not been terminated as defined in the Issuer's 2023 Employment Inducement Award Plan. All shares will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason.
Documents
Issuer
ZEVRA THERAPEUTICS, INC.
CIK 0001434647
Entity typeother
Related Parties
1- filerCIK 0001681098
Filing Metadata
- Form type
- 4
- Filed
- Oct 9, 8:00 PM ET
- Accepted
- Oct 10, 7:17 PM ET
- Size
- 9.1 KB